of abnormally long stretches of the repetitive sequence, C-A-G. The authors found a significant excess of genes Transcription factor NF-B: friend or foe of with longer CAG repeats in adults with schizophrenia.
neurons?
This trend of having longer polyglutamine-stretches F Lezoualc'h, C Behl was also noted in parallel studies examining those with A major feature of NF-B is that it can be activated by bipolar disorder. On its own, this gene may be neither oxidative stress. This factor has been shown to play a necessary nor sufficient for the development of these major role in the transcriptional activation of defensive psychiatric diseases. However, in combination with genes during inflammatory responses. Recently, eviother genetic risk factors and environmental stresses, dence accumulated showing a close association of a this gene may increase disease susceptibility in an number of certain neuropsychiatric disorders with oxiadditive or multiplicative fashion. If the results of this dative stress and the activation of NF-B. While several study are replicated in the future, these new findings findings suggest a role for NF-B in the prevention of could be used to narrow the focus of drugs which treat neuronal cell death, others demonstrate that the supthese diseases, as well as target those at risk to develop pression of NF-B activity can render cells more resisthe illnesses. tant to exogenous insults. Therefore, it appears that this transcription factor may have different functions in neurons. This will ultimately lead to new insights into neurodegenerative events that are associated with oxi-Association of the dopamine receptor D4 (DRD4) dative stress conditions. gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based Polygenic inheritance and micro/minisatellites approach DE Comings JM Swanson, GA Sunohara, JL Kennedy, R Regino, It has been suggested that the identification of the E Fineberg, T Wigal, GJ LaHoste, S Wigal genes involved in complex polygenic traits may be difficult. This paper suggests that the principles learned Attention deficit hyperactivity disorder (ADHD) is the in the past century about single gene disorders may not most common psychiatric disorder of childhood. There be relevant to polygenic inheritance and that the is considerable evidence supporting a genetic compomutations associated with polygenic disorders may be nent in the etiology of the disorder. Since stimulant fundamentally different. It is proposed that Z-DNA formedications act primarily on the dopamine system, a ming micro-and minisatellite polymorphisms, preferbiochemical basis of this disorder (a 'dopamine deficit') entially present in 5Ј non-coding sequences and has been hypothesized. Thus, genes within the dopaintrons, may play a role in the differential expression mine system are prime candidates for genetic studies. of many genes. As a result these genes exist in the The D4 receptor gene (DRD4) is of particular interest. population with many functional alleleomorphic vari-In a population-association study, the authors reported ants. While each variant has only a modest effect on a that DRD4 was associated with ADHD, with the 7 given phenotype, because the variants are common repeat variant occurring more frequently in a group of there is a reasonable probability that an individual will ADHD children than a group of controls. These new inherit a threshold number beyond which there is an data, from a family-based association study of 52 appreciable effect on the phenotype. parent-child trios, support the association of ADHD and this dopamine gene. When transmitted from parent IMMEDIATE COMMUNICATIONS to child, the 7 repeat variant of DRD4 may increase the Isolation of a novel potassium channel gene hSKCa3 risk for development of ADHD in the child. These data containing a polymorphic CAG repeat: a candidate are interesting since the 7 repeat variant may encode a for schizophrenia and bipolar disorder?
subsensitive dopamine receptor with regional distri-KG Chandy, E Fantino, O Wittekindt, K Kalman, bution in the brain areas related to attentional pro-L-L Tong, T-H Ho, GA Gutman, M-A Crocq, cesses.
R Ganguli, V Nimgaonkar, DJ Morris-Rosendahl, JJ Gargus
The authors of this study have identified a new human ion channel gene. This gene has the identifying quality hypothesis was presented in a previous study in which schizophrenia and a Thymine (T) to Cytosine (C) polya silent polymorphism in the serotonin 2A (5-HT 2A ) morphism at nucleotide position 102 in the 5HT 2A receptor gene, 102-T/C, was found to be associated receptor gene. In this study the authors also observed with clinical response to the antipsychotic clozapine. an association with the C allele in a sample of 63
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Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT 2A receptor gene and response to clozapine A family based association study of the T102C
In this work, associations between other polymorparent/offspring trios where the offspring received a phisms in the promoter and coding regions of the 5diagnosis of DSM-III-R schizophrenia. They demon-HT2A receptor, His452Tyr and -1438-G/A, and clinical strated that heterozygous parents were more likely to response in two independent samples of clozapinepass on the C than the T allele to their affected offtreated patients are reported. These results strengthen spring. However, this polymorphism does not result in the candidacy of serotonin receptors as therapeutic taran alteration of the amino acid sequence of the protein.
gets and reinforce the hypothesis of genetic variation The authors therefore tested the hypothesis that the influencing clinical response to antipsychotics. T102C polymorphism does not itself confer susceptibility to the disorder but is linked to a functionally rel-Linked polymorphisms upstream of exons 1 and 2 of evant polymorphism in the promoter. Such a tightly the human cholecystokinin gene are not associated linked polymorphism was found but initial functional with schizophrenia or bipolar disorder analysis did not demonstrate an effect of this polymor-T Bowen, N Norton, NJO Jacobsen, C Guy, phism on promoter activity. Previous studies have suggested that the gene coding R Gade, D Muhleman, H Blake, J MacMurray, for CCK is a candidate locus for susceptibility to P Johnson, R Verde, G Saucier, D Comings schizophrenia and/or bipolar disorder. Consequently, the three DNA sequences coding for CCK (CCK exons Abnormalities in monoamine oxidase (MAO) levels 1, 2 and 3), as well as the DNA sequences immediately have been implicated in a wide range of psychiatric flanking these exons, were analyzed using established disorders. A variable tandem repeat polymorphism is mutation detection techniques. Variants were detected associated with the MAOA gene. Since the MAO genes in the sequences immediately upstream from both exon are located on the X-chromosome, and are thus present 1 and exon 2. Comparison of the prevalence of these in single copy in males, they provide a particularly polymorphisms was carried out between groups of suitable test of the hypothesis that different sized individuals diagnosed with either schizophrenia or alleles may have differing effects on gene function and bipolar disorder and matched groups of unaffected thus on the phenotypic effects of the MAOA gene. The individuals. The resultant findings suggested that variauthors examined two independent groups: 375 TS ation in this gene does not underlie susceptibility to patients, relatives and controls, and 280 substance abueither disorder. sers and controls. There was a significant association between the MAOA gene and behavioral phenotypes The dopamine D 3 receptor (DRD3) Ser 9 Gly in both groups, and in both the longest alleles were polymorphism and schizophrenia: a haplotype associated with the greatest phenotypic effect. The relative risk study and association with clozapine strongest effect was for the diagnosis of drug depenresponse dence (P = 0.00003). The VNTR allele groups were in AK Malhotra, D Goldman, RW Buchanan, W Rooney, significant linkage disequilibrium with the Fnu4H1 A Clifton, MH Kosmidis, A Breier, D Pickar polymorphism previously shown to be associated with MAO-A activity. While direct correlations with The dopamine D 3 receptor (DRD3) Ser 9 Gly polymorenzyme activity also need to be done, these results are phism has been associated with schizophrenia and consistent with the possibility that different sized response to the atypical antipsychotic clozapine. To alleles of the short-repeat polymorphisms may play a investigate this association, the authors examined the DRD3 polymorphism in relation to schizophrenia and role in gene regulation.
to clozapine response with a haplotype relative risk posed on the basis of effective treatments and provocation tests. The authors hypothesized that variation in study group, and did not find increased transmission of DRD3 Ser 9 Gly alleles to schizophrenic offspring or the A 1 and A 2a adenosine receptor genes, which mediate the anxiogenic effects of caffeine, modifies significant differences in allele or genotype frequencies between schizophrenic patients and their parents. In genetic susceptibility to panic disorder. They therefore screened 38 patients with panic disorder (DSM-III-R) 68 patients treated with clozapine for 10 weeks, the authors did not find a significant association between for mutations in the coding sequences of their A 1 and A 2a adenosine receptor genes. A case-control associ-DRD3 and clozapine response. These data suggest that allelic variation in DRD3 does not play a role in schizo-ation study between the detected variants and panic disorder was performed in an extended sample of 89 phrenia or in the interindividual variation in clozapine response.
patients and matched controls. No coding variant was detected in either of the two genes, but an association was observed between a silent polymorphism of the Serum leptin levels increase rapidly after initiation A 2a adenosine receptor gene and panic disorder. This of clozapine therapy finding suggests a contribution of the A 2a adenosine T Brö mel, WF Blum, A Ziegler, E Schulz, M Bender, receptor gene to the development of panic disorder.
C Fleischhaker, H Remschmidt, J-C Krieg,
This is consistent with the recent observation of J Hebebrand increased anxiety in a mouse A 2a adenosine receptor knockout-model. Weight gain is a major side-effect of clozapine, an atypical neuroleptic drug, which is used for treatment Predisposition of Wolfram syndrome heterozygotes of schizophrenia. The authors hypothesized that this to psychiatric illness drug leads to an alteration of serum leptin levels upon RG Swift, MH Polymeropoulos, R Torres, M Swift initiation of treatment. Serum leptin levels were measured in 12 patients at baseline and for a 10-week period
Although it is generally accepted that many common after initiation of treatment. During the first 2 weeks of psychiatric disorders are attributable to genetic predistreatment serum leptin levels at least doubled in eight position, no gene responsible for a common psychiatric of the 12 patients. The maximal relative increase over disorder has yet been identified. Wolfram syndrome, baseline was more than five-fold. Low doses of clozawhich is defined by the occurrence of diabetes mellitus pine were sufficient to induce this effect. Within the and progressive bilateral optic atrophy, is a neurodeg-10-week period, mean body weight, mean body mass enerative autosomal recessive syndrome. Wolfram synindex, mean fat mass and mean lean body mass all drome homozygotes suffer from a wide variety of psyincreased. The authors therefore suggest that in predischiatric disturbances. Localization of the Wolfram posed individuals clozapine induces an increased syndrome gene to chromosome 4p now makes it posappetite and/or hunger via central mechanisms, caussible to test whether Wolfram syndrome heterozygotes ing gain in fat mass and increased leptin secretion.
are similarly predisposed to psychiatric illness. Using molecular genotyping, the authors establish that heterozygous carriers of the Wolfram syndrome gene are Systematic mutation screening and association study 26-fold more likely to be hospitalized for depression of the A 1 and A 2a adenosine receptor genes in panic and/or attempted suicide than non-carriers. Assuming disorder suggest a contribution of the A 2a gene to the that such carriers constitute about 1% of the popudevelopment of disease lation, the authors estimate that approximately 25% of J Deckert, MM Nö then, P Franke, C Delmo, J Fritze, all people hospitalized for similar psychiatric dis-M Knapp, W Maier, H Beckmann, P Propping orders may carry this gene.
J Licinio, MD Panic disorder is the anxiety disorder with the strongest genetic influence. Candidate genes have been pro-Editor
